stockrowKoninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Return on equity
Koninklijke Philips N.V.'s return on equity over the twelve months to 30 September 2026 was 8.54%, up 0.6 percentage points from fiscal 2025 (7.95%). Over the past ten years it has ranged from −10.9% (fiscal 2022) to 25.6% (fiscal 2021); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of −10.4% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 7.95% | 13.77 |
| FY2024 | −5.82% | (2.09) |
| FY2023 | −3.73% | 7.16 |
| FY2022 | −10.9% | (36.45) |
| FY2021 | 25.6% | 15.78 |
| FY2020 | 9.78% | 0.59 |
| FY2019 | 9.19% | (0.04) |
| FY2018 | 9.23% | (3.90) |
| FY2017 | 13.1% | 1.70 |
| FY2016 | 11.4% | 6.25 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 37.7% |
| GEHC GE HealthCare Technologies Inc. compare | 19.9% |
| BSX Boston Scientific Corporation compare | 14.2% |
| STE STERIS plc compare | 11.6% |
| EW Edwards Lifesciences Corporation compare | 9.65% |
| PHG Koninklijke Philips N.V. | 8.54% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.02% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| GKOS Glaukos Corporation compare | −22.8% |
| Medical Devices industry median | −10.4% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement